Angela Zubel, chief development officer, Debiopharm, explains how AI-enabled site selection, patient allocation, and ...
In today’s ACT Brief, we examine how AI is shifting from pilot programs into daily development workflows, how a new adoption ...
Findings from the VA’s Diuretic Comparison Project show pragmatic trial designs can achieve strong provider participation when burden is minimized and patient care remains the primary focus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results